Edesa Biotech, Inc.EDSANASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank47
3Y CAGR-14.1%
5Y CAGR-44.6%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
-14.1%/yr
Annual compound
5Y CAGR
-44.6%/yr
Recent acceleration
Percentile
P47
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $539121.00 | -25.8% |
| 2025 | $726843.00 | -14.0% |
| 2024 | $845499.00 | -0.4% |
| 2023 | $849143.00 | +3.2% |
| 2022 | $822666.00 | -92.0% |
| 2021 | $10.34M | +27535.5% |
| 2020 | $37412.00 | +112.1% |
| 2019 | $-309445.00 | -871.7% |
| 2018 | $40101.00 | -79.4% |
| 2017 | $194698.00 | - |